| Date Filed | Type | Description |
| 05/11/2023 |
4
| Dier Mardi (CFO and CBO) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Bought 5,556 shares
@ $18, valued at
$100k
Bought 875 shares
@ $18, valued at
$15.8k
Bought 875 shares
@ $18, valued at
$15.8k
Disposed of 673,621 options to buy
@ $5.8766, valued at
$4M
Acquired 673,621 options to buy
@ $5.8766, valued at
$4M
Disposed of 85,226 options to buy
@ $18, valued at
$1.5M
Acquired 85,226 options to buy
@ $18, valued at
$1.5M
|
|
| 05/04/2023 |
4
| Dier Mardi (CFO and CBO) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Granted 85,226 options to buy
@ $18, valued at
$1.5M
|
|
| 05/04/2023 |
3
| Dier Mardi (CFO and CBO) has filed a Form 3 on ACELYRIN, Inc. |
| 10/17/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 1,629 shares
@ $40.16, valued at
$65.4k
|
|
| 10/14/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 3,484 shares
@ $38.22, valued at
$133.2k
|
|
| 09/19/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/22/2022 |
4
| Dier Mardi (Director) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 34,300 options to buy
@ $4.74, valued at
$162.6k
|
|
| 06/17/2022 |
4
| Dier Mardi (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 53,700 options to buy
@ $3.75, valued at
$201.4k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2021 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 3,477 shares
@ $82.79, valued at
$287.9k
Sold 3,261 shares
@ $81.16, valued at
$264.7k
|
|
| 06/22/2021 |
4
| Dier Mardi (Director) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 23,344 options to buy
@ $31.02, valued at
$724.1k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $5.21, valued at
$52.1k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $2.7, valued at
$27k
|
|
| 04/27/2020 |
4
| Dier Mardi (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 33,250 options to buy
@ $16, valued at
$532k
|
|
| 04/23/2020 |
3
| Dier Mardi (Director) has filed a Form 3 on Oric Pharmaceuticals, Inc. |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 16,250 shares
@ $0
Paid exercise price by delivering 3,435 shares
@ $12.89, valued at
$44.3k
Granted 65,000 options to buy
@ $12.79, valued at
$831.4k
|
|
| 01/14/2020 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 2,125 shares
@ $0
Paid exercise price by delivering 1,277 shares
@ $13.8, valued at
$17.6k
|
|
| 06/06/2019 |
4
| Dier Mardi (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 10,000 options to buy
@ $4.8, valued at
$48k
|
|
| 05/21/2019 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 5,859 shares
@ $0
Paid exercise price by delivering 3,022 shares
@ $28.69, valued at
$86.7k
Exercised 5,859 rights
@ $0 |
|
| 04/08/2019 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Sold 40,486 shares
@ $37.3913, valued at
$1.5M
|
|
| 03/05/2019 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,667 shares
@ $33.41, valued at
$323k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2019 |
4
| Dier Mardi (EVP, CFO & CBO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 2,125 shares
@ $0
Paid exercise price by delivering 868 shares
@ $24.25, valued at
$21k
|
|
| 09/05/2018 |
4
| Dier Mardi (Interim Co-President & CFO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 17,500 shares
@ $0
Paid exercise price by delivering 8,884 shares
@ $29.1764, valued at
$259.2k
|
|
|